Allogene Therapeutics Reports Second Quarter 2022 Financial Results
Go back to Allogene Therapeutics Reports Second Quarter 2022 Financial Results| (NASDAQ: ALLO) | Delayed: 2.05 -0.04 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $ | |||
| Open | $2.11 | 52 Week Low | $ | |||
| Day High | $2.11 | P/E | N/A | |||
| Day Low | $2.00 | EPS | $ | |||
| Volume | 1,905,289 | |||||

